[First results of the clinical use of injectable lysine acetylsalicylate].
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000008:administration & dosage* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D005998:Glycine / Q000008:administration & dosage*; D006261:Headache / Q000188:drug therapy; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007592:Joint Diseases / Q000188:drug therapy; D008239:Lysine / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D009443:Neuritis / Q000188:drug therapy; D010003:Osteoarthritis / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy*
D000700:Analgesics; D004338:Drug Combinations; D008239:Lysine; D001241:Aspirin; D005998:Glycine
Primi rilievi sull'impiego clinico dell'acetilsalicilato di lisina iniettabile.